Advertisements

Матерна

Quick links to important sections

Матерна

Advertisements
Advertisements

Treatment option: Pregnancy

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Матерна

Quick Facts

Property Description
Active Ingredients Multivitamins (e.g., Folic Acid, Vitamin D), Minerals (e.g., Iron, Calcium), and often Omega-3 Fatty Acids (DHA)
Form Oral Tablet, Capsule, or Softgel
Pharmacological Class Multivitamin and Mineral Combinations / Nutritional Supplement
Common Use Nutritional support for periods of high metabolic demand
Origin Synthetic and Derived Components

What is Матерна and What Class Does it Belong To?

Матерна is a specialized Multivitamin and Mineral (MVM) Combination Product classified as a Nutritional Supplement designed to support the heightened needs of women during key reproductive phases. Its identity is rooted in its tailored concentration of micronutrients, positioning it distinctly from general adult vitamin formulations. This preparation is typically offered as an over-the-counter (OTC) supplement intended for oral administration and is manufactured in several specialized forms, including a standard Tablet or a Softgel, often to accommodate the stable incorporation of lipid-soluble components.

Composition of Матерна: Vitamins, Minerals, and Differentiation

The composition of Матерна is based on a comprehensive blend of essential micro- and macro-nutrients, utilizing both synthetic components (such as the B-vitamins) and derived components (such as Fish Oil for DHA). The formulation delivers critical water-soluble and fat-soluble vitamins, alongside essential trace elements and minerals such as Iron, Calcium, Iodine, and Zinc. This combination is designed for the targeted support of specific micronutrient needs unique to pregnancy. The distinctiveness of the formulation lies in the inclusion of Folic Acid and Iron at levels intended to support the reduction of risk for neural tube defects and maternal anemia.

What is the General Purpose of Taking Матерна?

The general purpose of this product is to provide systematic nutritional support and act as a resource pool for the body, thereby sustaining maternal nutrient stores when dietary intake may be inadequate to meet elevated physiological requirements. The formula functions by supplying necessary cofactors and substrates that aid in crucial biological processes, including supporting DNA synthesis, hematopoiesis, and the structural development of the fetal central nervous system. Its utility is to provide a consistent supply of essential components, thereby bridging the nutritional gap associated with increased metabolic demands during the pre-conception and gestation periods.

Advertisements

What side effects are possible with Матерна?

Possible Side Effects and Safety Information

This section outlines officially documented adverse reactions and safety restrictions for Матерна, strictly based on government regulatory documentation.

Adverse Reactions Scope

Adverse reactions are generally classified into expected, common effects, and rare but serious reactions requiring immediate attention.

Classification Examples of Reactions (System-Organ Class)
Common Side Effects (Gastrointestinal) Constipation, nausea, vomiting, diarrhea, upset stomach, or belly pain.
Immunologic/Skin Reactions (Uncommon) Allergic reactions, rash, hives, and itching.

Serious Adverse Reactions

The most serious events documented include signs of an allergic reaction (such as swelling of the face, throat, or tongue, and severe trouble breathing). Other clinically significant safety events related to the iron content include signs of internal bleeding such as black, bloody, or tarry stools, or vomiting material that looks like coffee grounds.

Population-Specific Safety Considerations

  • Pediatric Safety: Accidental overdose of iron-containing products, including Матерна, is a leading cause of deadly poisoning in children under 6. The product must be stored securely away from the reach of children.
  • Vitamin A Toxicity: Individuals should be cautious about excessive intake of Vitamin A from other sources, particularly shortly before and during pregnancy, as high levels can be associated with potential fetal harm. Separately, prolonged intake of high-dose Vitamin A (not from beta-carotene) may increase the risk of osteoporosis in postmenopausal women.

Safety-Related Restrictions

Patients who experience any symptoms of a severe allergic reaction or signs of internal bleeding must seek immediate medical care. The regulatory focus mandates a prominent warning concerning the risk of accidental iron poisoning in the pediatric population.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for this multivitamin and mineral product is primarily defined by the acute toxicity risk of its Elemental Iron component, which is documented by regulatory authorities as a severe, life-threatening scenario.

Documented Manifestations and Severe Outcomes

Overdose may initially present with severe gastrointestinal distress, including nausea, vomiting (potentially bloody), abdominal pain, and bloody diarrhea. As documented in regulatory sources, these symptoms can progress rapidly to systemic involvement, including lethargy, confusion, and eventually, life-threatening outcomes such as shock, coma, and hepatic failure.

Accidental ingestion of iron-containing products is the leading cause of fatal poisoning in children younger than six years and carries a risk of spontaneous abortion if ingested by a pregnant individual in toxic amounts.

Required Emergency Action

Regulatory guidance mandates that immediate medical attention must be sought right away in all cases of suspected overdose. It is essential to contact a poison control center or emergency medical services immediately, even if the individual appears well or if the initial symptoms have subsided, due to the high risk of delayed but severe toxicity. Management procedures, including supportive care and chelation therapy (an antidote for severe iron toxicity), require hospitalization and continuous monitoring.

Advertisements

Therapeutic Uses of Матерна

The use of Матерна is directed toward comprehensive nutritional support during the reproductive lifecycle, specifically targeting the mitigation of developmental risks and the management of symptoms associated with high physiological demands. The daily intake of a vitamin containing folic acid is intended for the purpose of helping to prevent certain birth defects in women who can become pregnant.

The supplement is commonly used across conditions presenting with increased physiological stress to help address symptoms related to potential Iron-Deficiency Anemia, such as maternal fatigue, weakness, and diminished vitality. It is relevant for assisting with a consistent supply of essential micronutrients required during periods of high metabolic demand; it is also applicable in contexts marked by pre-conception planning and lactation.

Quick Fact: Support for Nutritional Gaps

Therapeutic Focus Primary Benefit Use Contexts
Fetal Risk Mitigation Contributes to reducing the risk for Neural Tube Defects (NTDs). Pre-conception and Gestation
Maternal Support Supports the management of symptoms related to systemic imbalance. Pregnancy and Lactation

Key Therapeutic Focus

The core therapeutic domains include reduction of fetal neural tube defect risk, support for maternal energy and anemia prevention, and bridging nutritional gaps across the entire reproductive cycle. The overall goal is to provide supportive benefits that may assist with maintaining a sense of stability and day-to-day comfort.

“The product is relevant for assisting patients during periods of increased discomfort or tension, which may be associated with physiological stress during the critical phases of development.”

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Матерна? (Population Eligibility)

The eligibility profile for Матерна (a specialized Multivitamin and Mineral product) is defined by its intended use and specific contraindications documented in official regulatory labeling. This profile outlines which populations are permitted or restricted from using the product.


Populations for Whom Use is Allowed

Матерна is officially indicated for adult women during key phases of the reproductive lifecycle. This includes supplementation prior to conception, throughout pregnancy, and during the postnatal period, including for both lactating and non-lactating mothers.


Contraindications and Restrictions

Use of the medicine is contraindicated for any patient with a known hypersensitivity to any of the ingredients of the product. Additionally, it must not be used by patients diagnosed with untreated and uncomplicated pernicious anemia, as the folic acid component may mask symptoms of an underlying Vitamin B12 deficiency.

Regulatory documents also advise caution for individuals with hypercalcemia or those taking certain medications, such as levodopa, as one of the vitamin components may antagonize its action.


Age-Group and Special Considerations

Official labeling states that the safety and effectiveness of the product have not been established in pediatric patients. For older adults (aged 65 and over), clinical data is often insufficient, and caution is advised due to the greater frequency of decreased hepatic or renal function in this group.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory information for Матерна, a multivitamin and mineral supplement, focuses primarily on interactions driven by its mineral content (Iron and Calcium) and specific vitamins.

Documented Interaction Patterns

Co-administration with several medicinal products may result in a reduction in systemic exposure of the co-administered drug. The Iron component officially interferes with the absorption of Levothyroxine (thyroid hormone), while the Calcium and Iron components bind to antibiotics, including Quinolones and Tetracyclines, reducing their absorption via a chelation-based interference.

To mitigate this reduction in exposure, regulatory documents mandate timing separation. Administration of the supplement must be separated from Levothyroxine, commonly by at least four hours, and from certain antibiotics, typically by two to six hours.

Pharmacodynamic and Substance Interactions

Official labeling documents a pharmacodynamic additive effect with Thiazide Diuretics, where the co-administration of Calcium and Vitamin D increases the documented risk of hypercalcemia.

Furthermore, the Folic Acid component is officially stated to potentially interfere with the therapeutic efficacy of Methotrexate. Certain Phytate and Oxalate-containing Foods are documented to reduce the bioavailability of Iron and Calcium, and chronic, high-volume alcohol consumption may reduce Folic Acid absorption. The combination with Deferoxamine is officially restricted or contraindicated due to the high Iron content.

Advertisements

Mechanism of Action

How Матерна Works

The mechanism of action for this product relies on supplying essential nutritional cofactors and structural substrates to sustain highly accelerated metabolic and developmental demands, operating via biochemical roles rather than receptor modulation.

Role in DNA Synthesis and Cellular Proliferation

Water-soluble components, primarily Folic Acid and Vitamin B12, function as coenzymes within the one-carbon metabolism pathway. By supporting the synthesis of purines and pyrimidines, this mechanism sustains the necessary biochemical environment for DNA replication required for rapid cell division in developing tissues, which is foundational to the formation of organized embryonic structures.

Hematopoiesis and Oxygen Transport Capacity

This mechanism centers on the coordination between Iron and hematopoietic cofactors. Iron is incorporated as the prosthetic group of Hemoglobin, while B vitamins ensure the proper maturation of red blood cell precursors. This coordinated supply supports full-scale erythropoiesis, increasing the body’s systemic capacity for oxygen transport and supporting the physiological mechanism of blood volume expansion.

Structural Integration into Neuronal Membranes

The DHA component is directly integrated into the phospholipid bilayer of neuronal cell membranes, particularly in the fetal brain and retina. This structural modification modulates membrane fluidity and function, thereby sustaining efficient signal transduction and connectivity in the central nervous system.

Advertisements

Dosage and Administration Information

How to Use Матерна: Administration Guidelines

Матерна, or equivalent prenatal multivitamin and mineral supplements, is administered solely through the oral route as a fixed-dose unit, typically in a coated tablet or a combination pack that includes a softgel capsule. Standard dosing instructions prescribe a schedule of one unit taken once daily.

Administration Scope Standard Requirement
Dosing Schedule One tablet daily (fixed dose)
Frequency Once Daily
Timing with Meals Must be taken with food or with a meal

Use of the product is directed toward specific periods of the reproductive life cycle. Standard use involves continuous, standardized use prior to conception, throughout pregnancy, and during the postnatal period (lactation). This duration establishes a continuous daily regimen rather than a cyclic course.

Procedurally, the tablet and/or softgel must be swallowed whole. Standard administration includes taking the product a few hours before or after other medications or natural health products to avoid potential administration conflicts. The overall structure of use is non-titrated and remains standardized for the target population, as no specific adjustments for age or organ function are provided in the product labeling for this product class.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Матерна

This overview summarizes the research that has been conducted on the components of specialized multivitamin and mineral (MVM) supplements, like Materna, focusing on what types of studies exist, what they measured, and what remains unclear according to authoritative sources. The findings described here reflect group patterns observed in studies and are not personal predictions.


Research Evidence for Supporting Fetal Neural Development

Research on these supplements was studied for outcomes related to specific birth risks. The evidence base includes many Randomized Controlled Trials (RCTs) and Systematic Reviews that focused on the Folic Acid component. These studies research examined whether taking the supplement during the preconception period and the first trimester was associated with differences in the incidence and recurrence of Neural Tube Defects (NTDs), such as spina bifida.

Studies report patterns observed in the research populations where supplementation with Folic Acid was associated with a lower measured incidence of NTDs. This pattern was observed in some studies regardless of the mother's previous pregnancy history. The independent contribution of the many other vitamins and minerals in the full MVM formulation, beyond Folic Acid, to addressing this risk data are still emerging, and long-term effects are not fully established.


Research Evidence for Supporting Maternal Blood Status

Research was evaluated in studies designed to monitor outcomes related to systemic or functional imbalance, specifically focusing on maternal iron levels during pregnancy. These studies, which include numerous RCTs and Systematic Reviews, monitored changes in maternal Hemoglobin (Hb) levels and the occurrence of Iron-Deficiency Anemia (IDA) throughout gestation. The studies described patterns observed where supplementation protocols including the Iron component were associated with higher measured Hb levels and reported a lower incidence of diagnosed clinical anemia compared to non-supplemented groups.

Comparative evidence is lacking between women taking the full MVM formulation and those taking only Iron and Folic Acid, especially in well-nourished populations. Results apply only to the populations studied, meaning findings were observed to vary based on a woman's initial nutritional status.


Research Evidence on Fetal Growth and Birth Outcomes

Research was evaluated in large RCTs that research examined whether providing a Multiple Micronutrient (MMN) supplement resulted in differences in fetal growth measurements compared to standard Iron and Folic Acid (IFA) alone. The main outcomes studies explored included rates of Low Birth Weight (LBW) and Small-for-Gestational-Age (SGA) birth.

In studies conducted in low- and middle-income countries (LMICs), findings suggest that MMN supplementation was associated with a lower measured incidence of LBW and SGA birth compared to IFA alone. However, in trials involving well-nourished populations, the research describes that the measured difference between MMN and IFA on these fetal growth outcomes was often negligible. The specific roles of certain individual micronutrients within the combination in influencing birth weight outcomes remain uncertain.


Long-term Studies and Follow-up Data

The evidence base also includes research that extends beyond delivery to assess longer-term infant neurocognitive development outcomes, specifically addressing outcomes related to the Omega-3 Fatty Acid (DHA) component. Findings were mixed across different studies and populations. The evidence contributes to understanding symptom patterns but long-term effects are not fully established and certainty remains low for this specific outcome across the general population.

Key Studies & References

  1. Antenatal care: multiple micronutrient supplements during pregnancy
  2. What is the relationship between omega-3 fatty acids from supplements consumed before and during pregnancy and lactation and developmental milestones, including neurocognitive development, in the child? | Nutrition Evidence Systematic Review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Матерна (FAQ)

Q: How does Матерна differ from other common prenatal vitamins?

A: Official labeling documents describe Матерна and similar products as specialized multivitamin and mineral combinations. The formulation is tailored to provide specific concentrations of essential micronutrients, such as Folic Acid and Iron, aligning with international health guidelines for the pre-conception and pregnancy periods. This tailored concentration is what distinguishes it from general adult vitamin formulas.

Q: Does Матерна affect sleep patterns or energy levels?

A: Regulatory documents do not explicitly list effects on sleep as a common adverse reaction for this product class. However, components like B-vitamins and Iron function as cofactors in the body's energy-yielding metabolism and oxygen transport processes. These systemic roles can sometimes be associated with overall energy levels and changes in fatigue.

Q: What happens if the package insert for Матерна is unclear?

A: If clarification is required on the product information, detailed regulatory documents, such as the full product label (DailyMed or SmPC) or official drug information summaries (MedlinePlus), are generally maintained and available online through government databases. These sources provide the most authoritative text for review.

Q: Are there specific symptoms that should prompt a discussion with a healthcare provider while on Матерна?

A: Official safety documents advise reporting any signs of a serious allergic reaction (e.g., swelling or difficulty breathing) immediately. Additionally, any side effects that are severe or persistent, like ongoing constipation, nausea, or vomiting, may warrant a discussion with a healthcare provider, as outlined in the official patient information.

Q: Does Матерна contain iron, and if so, how much?

A: Yes, official product labels confirm that Матерна contains an Iron component, included for its role in supporting maternal blood status and red blood cell production. The specific amount of iron per dose is documented in the product's official composition table, which is available in the full regulatory labeling.

Q: Are there documented cases of serious drug interactions with Матерна?

A: Regulatory documents describe potential interactions primarily driven by the Iron and Calcium content. These minerals can interfere with the absorption of certain co-administered medicines, such as thyroid hormones (Levothyroxine) or certain antibiotics (e.g., Quinolones). Official guidance often requires a timing separation to mitigate this effect.

Q: Can Матерна be taken on an empty stomach?

A: Official administration guidelines consistently state that the product is intended to be taken with food or a meal. Official documents indicate that gastrointestinal side effects may be more frequent if the product is not consumed with food, and consuming it with food may also aid in the absorption of certain nutrients.

Q: Why is the information on side effects sometimes confusing?

A: Official information classifies adverse reactions based on their observed frequency in studies (e.g., Common or Uncommon). User confusion may arise because this classification reflects the statistical incidence in a large group, and the individual experience of side effects can be highly variable and non-clinical in nature.

Q: What does the official monograph say about interactions with herbal supplements?

A: Official regulatory documents, such as those issued by Health Canada, often provide generalized guidance to separate the administration of Матерна from other natural health products or certain herbal products by a few hours. This is done to prevent potential administration conflicts or interference with nutrient absorption.

Q: Is Матерна available over the counter, or does it require a prescription?

A: This product class, a multivitamin and mineral combination, is generally classified as a Dietary Supplement by regulatory bodies. While many formulations are marketed for Over-The-Counter (OTC) availability, some specialized versions or combinations may be designated as prescription-only products.

Q: Are there specific components in Матерна that cause weight gain?

A: Official information indicates that multivitamin and mineral supplements do not directly cause weight gain, as they provide negligible calories. However, a common side effect of the iron component is gastrointestinal upset or constipation, which some individuals may associate with temporary feelings of bloating or heaviness.

Q: Are there different versions or formulations of Матерна?

A: Official regulatory databases confirm that this product is marketed in different formulations and presentations, such as a standard tablet, a softgel capsule, or a combination pack. These versions may vary slightly in the type of nutrient used (e.g., the specific Iron salt) or the inclusion of components like DHA.

Q: Is Матерна typically taken at a specific time of day?

A: The official administration instructions specify that the product is to be taken Once Daily and that it should be taken with food or a meal. Beyond the requirement for co-administration with food, the regulatory documents do not typically mandate a specific time of day, such as morning versus evening.

Q: Are there special considerations for using Матерна in people with kidney issues?

A: Official labeling for this class of product often includes statements advising caution for individuals with pre-existing conditions. For example, caution is explicitly advised for older adults due to the higher frequency of decreased renal (kidney) function.

Q: Is the absorption of Матерна affected by coffee or tea?

A: Regulatory documents list interactions with food components. While coffee and tea may not be explicitly named, these beverages contain compounds that are recognized to potentially interfere with the absorption of minerals like Iron, a primary component of Матерна.

Q: Does Матерна have an official safety rating from a major health organization?

A: Regulatory bodies like the U.S. FDA typically classify this product class as Dietary Supplements. As such, the FDA does not grant pre-market approval for efficacy and safety, but the products are subject to strict Good Manufacturing Practices (GMP) and quality standards.

Q: Can men use Матерна, and what would the purpose be?

A: The official indications for this product are explicitly focused on women during the reproductive phases: prior to conception, throughout pregnancy, and during the postnatal period. The product is not labeled for use outside of this target population.

Q: Does Матерна contain any artificial colors or preservatives?

A: The official product label details both the Active Ingredients (vitamins and minerals) and a separate list of Inactive Ingredients. The inactive ingredients list documents all components used in the formulation of the tablet or capsule, including any colorants, preservatives, or coatings.

Q: Is the source of the ingredients in Матерна regulated?

A: Yes, as a dietary supplement product, the manufacturer must adhere to Good Manufacturing Practices (GMP) regulations, which are enforced by regulatory agencies like the FDA. These regulations govern all aspects of production and sourcing to ensure the product meets established quality standards.

Q: Do official sources describe any expected changes in urine color when taking Матерна?

A: While not always listed under common side effects, the ingestion of high-dose B-vitamins, especially Riboflavin (Vitamin B2), is commonly known to cause the urine to appear a brighter yellow color. This is a normal, non-harmful effect of the body processing and excreting the water-soluble vitamin.

Q: Are there alternatives to Матерна for people with specific dietary restrictions?

A: The official documentation describes the full composition of the product, including all active and inactive ingredients, such as potential allergens like Fish Oil for DHA. This information allows users to review the components to determine if the product contains any substance that conflicts with specific dietary or allergy restrictions.

Q: How is the safety of Матерна monitored after it is made available to the public?

A: Safety is monitored continuously through post-marketing surveillance. This involves government systems, such as the FDA’s Adverse Event Reporting System (AERS), where healthcare providers and consumers can voluntarily report any suspected side effects that occur after the product is made available.

Q: Is there a generic version of Матерна?

A: Yes, because Матерна belongs to a class of multi-component nutritional supplements, numerous generic or chemically equivalent formulations are available. These products are marketed under different names but contain the same core combination of essential vitamins and minerals.

Q: Do the ingredients in Матерна work together in a specific way?

A: Yes, the product’s mechanism of action is based on the coordinated supply of essential nutritional cofactors. For example, B-vitamins and Iron are described as working together to support red blood cell maturation and increase the body’s overall capacity for oxygen transport.

Q: Is there any evidence that Матерна helps with fertility or conception?

A: The official indication includes use prior to conception to provide nutritional support. Research has examined the relationship between supplementation during the preconception period and outcomes related to birth risks, specifically focusing on the Folic Acid component.

Advertisements

How should Матерна be stored and disposed of?

How to Store and Dispose of Materna

Materna must be stored strictly according to the conditions defined in the official labeling to ensure product integrity and safety.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, between 15 C to 30 C (59 F to 86 F).
Protection Keep the container tightly closed and protect from light and moisture to prevent tablet erosion.
Safety Keep this and all medication out of the reach of children. The iron content poses a risk of serious poisoning.

Disposal Instructions

Do not dispose of unused or expired Materna in household trash or by flushing it down the toilet. Follow the labeled instructions to dispose of the product through a community drug take-back program or by adhering to specific guidance provided by local waste authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Матерна found in:

A-Z Index: